List view / Grid view
If the proposed USP Chapter < 86 > on using…
If the proposed USP Chapter < 86 > on using non-animal derived reagents is approved, it will be published for early adoption in November 2024, USP states.
As a “major manufacturer of the world’s medicines”, the Indian…
As a “major manufacturer of the world’s medicines”, the Indian Pharmacopoeia Commission (IPC) has joined the Pharmacopoeial Discussion Group (PDG) to contribute to the harmonisation of quality standards.
A monograph outlining the analytical methods and acceptance criteria for…
A monograph outlining the analytical methods and acceptance criteria for cannabis chemotypes has been released for comment by USP’s Herbal Medicines Compendium.
USP is developing mRNA quality guidelines to support the development…
USP is developing mRNA quality guidelines to support the development of innovative medicines and vaccines.
The British Pharmacopoeia and United States Pharmacopeia partnership is to…
The British Pharmacopoeia and United States Pharmacopeia partnership is to be formalised to strengthen the quality of medicines and public health.
